Senior Manager - HTA
Beverley Jones has worked as medical writer for almost 15 years and has worked in Health Technology Assessment (HTA) since 2010, reviewing, preparing and supporting reimbursement submissions to HTA bodies. During her six years at HEOR, Beverley has been involved in reimbursement submissions in a wide range of disease areas, including hepatitis C, HIV, haematological malignancies, gastrointestinal tumours, rare diseases, chronic kidney disease, diabetes, chronic heart disease and iron deficiency anaemia. Her experience includes HTA submissions to UK HTA bodies (NICE, SMC and AWMSG) and global agencies (CADTH, NCPE, PBAC and HAS).
Beverley and the HTA team also provide strategic consultation, including leading advisory boards and conducting mock appraisal committee meetings. Additionally, Beverley routinely conducts HTA landscape assessments and HTA feasibility assessments.
Prior to joining HEOR, Beverley worked at the All Wales Therapeutics and Toxicology Centre (AWTTC) supporting the All Wales Medicines Strategy Group (AWMSG), where she became highly familiar with the requirements and processes of UK HTA organisations. During her time at AWTTC, she authored critical appraisals of HTA submission across a variety of disease indications, providing a concise overview and assessment of the available evidence. Additionally, she conducted horizon scanning activities in support of timely identification of potential HTA submissions.